387 related articles for article (PubMed ID: 27569941)
1. Bone Disease and Serum Fibroblast Growth Factor-23 Levels in Renal Transplant Recipients.
Coskun Y; Paydas S; Balal M; Soyupak S; Kara E
Transplant Proc; 2016; 48(6):2040-5. PubMed ID: 27569941
[TBL] [Abstract][Full Text] [Related]
2. Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients.
Zheng S; Chen Y; Zheng Y; Zhou Z; Li Z
Eur J Med Res; 2018 Apr; 23(1):18. PubMed ID: 29665846
[TBL] [Abstract][Full Text] [Related]
3. Inverse Association Between Serum Osteoprotegerin and Bone Mineral Density in Renal Transplant Recipients.
Hsu BG; Chen YC; Ho GJ; Shih MH; Chou KC; Lin TY; Lee MC
Transplant Proc; 2016 Apr; 48(3):864-9. PubMed ID: 27234754
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral disorders in pediatric and adolescent renal transplant recipients.
Derakhshan A; Behbahan AG; Lotfi M; Omrani GH; Fallahzadeh MH; Basiratnia M; Al-Hashemi GH
Pediatr Transplant; 2011 Jun; 15(4):367-75. PubMed ID: 21429060
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-B-type natriuretic peptide is inversely related to bone mineral density in renal transplant recipients.
Lee MC; Lee CJ; Shih MH; Ho GJ; Chen YC; Hsu BG
Transplant Proc; 2014 Dec; 46(10):3443-7. PubMed ID: 25498069
[TBL] [Abstract][Full Text] [Related]
6. Loss of bone mineral density in renal transplantation recipients.
Unal A; Kocyigit I; Sipahioglu MH; Tokgoz B; Kavuncuoglu F; Oymak O; Utas C
Transplant Proc; 2010 Nov; 42(9):3550-3. PubMed ID: 21094813
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
Westeel FP; Mazouz H; Ezaitouni F; Hottelart C; Ivan C; Fardellone P; Brazier M; El Esper I; Petit J; Achard JM; Pruna A; Fournier A
Kidney Int; 2000 Oct; 58(4):1788-96. PubMed ID: 11012914
[TBL] [Abstract][Full Text] [Related]
8. Development of lumbar bone mineral density in the late course after kidney transplantation.
Brandenburg VM; Ketteler M; Fassbender WJ; Heussen N; Freuding T; Floege J; Ittel TH
Am J Kidney Dis; 2002 Nov; 40(5):1066-74. PubMed ID: 12407653
[TBL] [Abstract][Full Text] [Related]
9. Evolution of bone disease at 2 years after transplantation: a single-center study.
Falkiewicz K; Boratyńska M; Zmonarski SC; Milewicz A; Patrzałek D; Biecek P; Klinger M
Transplant Proc; 2009 Oct; 41(8):3063-6. PubMed ID: 19857677
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor-23 and parathyroid hormone are associated with post-transplant bone mineral density loss.
Kanaan N; Claes K; Devogelaer JP; Vanderschueren D; Depresseux G; Goffin E; Evenepoel P
Clin J Am Soc Nephrol; 2010 Oct; 5(10):1887-92. PubMed ID: 20634326
[TBL] [Abstract][Full Text] [Related]
11. Bone disease in long-term adult kidney transplant patients with normal renal function.
Montalban C; de Francisco AL; Mariñoso ML; Zubimendi JA; García Unzueta M; Amado JA; Arias M
Kidney Int Suppl; 2003 Jun; (85):S129-32. PubMed ID: 12753284
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.
Ersoy FF; Passadakis SP; Tam P; Memmos ED; Katopodis PK; Ozener C; Akçiçek F; Camsari T; Ateş K; Ataman R; Vlachojannis JG; Dombros AN; Utaş C; Akpolat T; Bozfakioğlu S; Wu G; Karayaylali I; Arinsoy T; Stathakis PC; Yavuz M; Tsakiris JD; Dimitriades CA; Yilmaz ME; Gültekin M; Karayalçin B; Yardimsever M; Oreopoulos DG
J Bone Miner Metab; 2006; 24(1):79-86. PubMed ID: 16369903
[TBL] [Abstract][Full Text] [Related]
13. Bone density, microarchitecture, and material strength in chronic kidney disease patients at the time of kidney transplantation.
Pérez-Sáez MJ; Herrera S; Prieto-Alhambra D; Vilaplana L; Nogués X; Vera M; Redondo-Pachón D; Mir M; Güerri R; Crespo M; Díez-Pérez A; Pascual J
Osteoporos Int; 2017 Sep; 28(9):2723-2727. PubMed ID: 28497224
[TBL] [Abstract][Full Text] [Related]
14. Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients.
Sit D; Kadiroglu AK; Kayabasi H; Atay AE; Yilmaz Z; Yilmaz ME
Adv Ther; 2007; 24(5):987-95. PubMed ID: 18029324
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density changes within 11 months of renal transplantation in Iranian patients.
Bayat N; Einollahi B; Pourfarzian V; Alishiri G; Nemati E; Bagheri N; Miri SM; Elizeii PK
Transplant Proc; 2007 May; 39(4):1039-43. PubMed ID: 17524886
[TBL] [Abstract][Full Text] [Related]
16. Inverse association of serum long-acting natriuretic peptide and bone mineral density in renal transplant recipients.
Hsu BG; Ho GJ; Lee CJ; Yang YC; Chen YC; Shih MH; Lee MC
Clin Transplant; 2012; 26(2):E105-10. PubMed ID: 22211802
[TBL] [Abstract][Full Text] [Related]
17. Long-term changes in bone mineral density in kidney transplant recipients.
Naylor KL; Garg AX; Hodsman AB; Rush DN; Leslie WD
Transplantation; 2014 Dec; 98(12):1279-85. PubMed ID: 25050472
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated With Lumbar and Femoral Bone Mineral Density in Kidney Transplants Candidates.
Aghighi M; Mahdavi Mazdeh M; Nafar M; Rakhshan V
Iran J Kidney Dis; 2017 Oct; 11(5):379-384. PubMed ID: 29038394
[TBL] [Abstract][Full Text] [Related]
19. Pamidronate therapy as prevention of bone loss following renal transplantation.
Fan SL; Almond MK; Ball E; Evans K; Cunningham J
Kidney Int; 2000 Feb; 57(2):684-90. PubMed ID: 10652047
[TBL] [Abstract][Full Text] [Related]
20. Determinants of bone mineral density in stable kidney transplant recipients.
Gupta AK; Huang M; Prasad GV
J Nephrol; 2012; 25(3):373-83. PubMed ID: 21928224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
